Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D21OLD
|
|||
| Drug Name |
BW-1010
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Anthrax [ICD-11: 1B97; ICD-9: 22] | Phase 1 | [1] | |
| Company |
BlueWillow Biologics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04148118) A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults (IN NE-rPA). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.